Page 4 - Largest Swedish (OMX) Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Apr 24, 2024

Discover large cap Swedish Pharmaceuticals & Biotech companies that are on the OMX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

124 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

NXTCL

NextCell Pharma
kr2.40-8.7%-60.3%kr82.5mn/aPS5.3xn/an/a

NEWBRY

Newbury Pharmaceuticals
kr3.39-3.1%-39.0%kr82.2mkr8.00PS3.6xE112.9%n/a

SPAGO

Spago Nanomedical
kr0.366.9%-53.5%kr80.4mn/aPS13.6xE54.4%n/a

ALZ

Alzinova
kr1.750%-31.4%kr77.9mkr12.00PS3.9xE-57.5%n/a

COMBI

CombiGene
kr3.80-1.3%-43.1%kr75.2mn/aPS10.7xn/an/a

ABERA

Abera Bioscience
kr4.74-2.3%-9.2%kr72.8mkr11.80PS27.5xS10.3%n/a

RESP

Respiratorius
kr0.240%-38.4%kr69.9mn/aPB2.6xS-39.9%n/a

ISAB

Inhalation Sciences Sweden
kr4.340%24.4%kr65.8mkr16.50PS3.8xS59.5%n/a

DBP B

Double Bond Pharmaceutical International
kr0.620%3.0%kr63.1mn/aPS46xn/an/a

ACUC

AcuCort
kr0.573.3%-63.0%kr61.7mn/aPS9.4xn/an/a

EEVIA

Eevia Health Oyj
kr1.6716.8%-38.8%kr59.6mn/aPS1xn/an/a

SCOL

Scandion Oncology
kr1.45-40.3%-20.1%kr58.8mkr3.20PB1.2xn/an/a

LIPUM

Lipum
kr6.25-4.6%-37.8%kr58.2mkr20.00PB12.7xE74.9%n/a

PILA

Pila Pharma
kr2.15-18.6%-24.0%kr51.2mn/aPS35xn/an/a

ONCOZ

OncoZenge
kr4.300.2%-49.1%kr50.3mn/aPS16769.5xE99.7%n/a

EMPLI

Emplicure
kr0.479.3%-68.5%kr46.5mn/aPB2.2xn/an/a

BIOSGN

Biosergen
kr0.32-34.3%-74.5%kr45.0mkr1.00PB21.3xS41.2%n/a

LPGO

Lipigon Pharmaceuticals
kr0.3522.4%-31.2%kr44.9mkr2.50PS2.7xE-35.0%n/a

COEGIN

Coegin Pharma
kr2.830%-79.2%kr44.7mn/aPB3.1xn/an/a

PROGEN

Prostatype Genomics
kr0.038-6.0%-91.9%kr37.5mn/aPS10xn/an/a

RLS

RLS Global
kr0.45-0.2%-84.2%kr35.6mkr7.00PS33.1xE92.8%n/a

MODTX

Modus Therapeutics Holding
kr1.00-1.5%-64.2%kr35.9mn/aPB2xE-28.8%n/a

CHOSA

Chosa Oncology
kr0.530%-59.3%kr34.4mn/aPB2xn/an/a

ELIC

Elicera Therapeutics
kr0.94-20.0%-73.9%kr33.0mn/aPS2.9xE-10.1%n/a
Page 4 of 6
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.